Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Eide

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Investigative Dermatology|December 10, 2013
Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosaJakub Tolar, John A McGrath, Lily Xia, et al.
The Journal of Investigative Dermatology|January 25, 2024
Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell CarcinomaCatherine A A Lee, Siyuan Wu, Yuen Ting Chow, et al.
Blood|August 15, 2002
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survivalJohn E Wagner, Juliet N Barker, Todd E DeFor, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Blood|December 23, 2022
Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivoTeresa L Ramos, Sara Bolivar-Wagers, Sujeong Jin, et al.
Blood|July 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host diseaseLie Ma, Brent H Koehn, Michael C Zaiken, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Investigative Dermatology|December 10, 2013
Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosaJakub Tolar, John A McGrath, Lily Xia, et al.
The Journal of Investigative Dermatology|January 25, 2024
Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell CarcinomaCatherine A A Lee, Siyuan Wu, Yuen Ting Chow, et al.
Blood|August 15, 2002
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survivalJohn E Wagner, Juliet N Barker, Todd E DeFor, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Blood|December 23, 2022
Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivoTeresa L Ramos, Sara Bolivar-Wagers, Sujeong Jin, et al.
Blood|July 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host diseaseLie Ma, Brent H Koehn, Michael C Zaiken, et al.
Pageof 2